• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生物信息学的早期卵巢癌自动检测系统

Automated early ovarian cancer detection system based on bioinformatics.

作者信息

Xiao Li, Li Hui, Jin Yanyang

机构信息

Department of Obstetrics and Gynecology, Jingzhou Hospital, Yangtze University, Jingzhou, 434020, China.

Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, 121001, China.

出版信息

Sci Rep. 2024 Oct 2;14(1):22887. doi: 10.1038/s41598-024-71863-9.

DOI:10.1038/s41598-024-71863-9
PMID:39358410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11447045/
Abstract

Ovarian cancer is a common gynecological tumor, with a high mortality rate and difficult clinical treatment. Early detection of ovarian cancer has significant diagnostic value. In response to the problem of poor diagnostic performance of traditional early diagnosis methods, this article designed an automated early ovarian cancer detection system to improve the detection of early ovarian cancer. The conventional early diagnosis methods include serum CA125 (carbohydrate antigen 125) detection and positron emission tomography/computed tomography (PET/CT) imaging. This article combined serum CA125 detection and PET/CT imaging to detect the CA125 level and maximum standardized uptake value (SUV) in patient's serum. When the CA125 level exceeded 35U/ml and the maximum SUV value exceeded 2.5, the test was considered positive. This article selected 200 patients from Jingzhou Hospital for the experiment and compared the three detection methods. The average specificity of single serum CA125 detection, single PET/CT imaging, and automated detection in patients under 50 were 61.24%, 79.57%, and 97.79%, respectively. The automated early ovarian cancer detection system designed in this article can significantly improve the specificity of early ovarian cancer detection and has excellent application value for early ovarian cancer detection.

摘要

卵巢癌是一种常见的妇科肿瘤,死亡率高,临床治疗困难。早期发现卵巢癌具有重要的诊断价值。针对传统早期诊断方法诊断性能不佳的问题,本文设计了一种自动化早期卵巢癌检测系统,以提高早期卵巢癌的检测水平。传统的早期诊断方法包括血清CA125(糖类抗原125)检测和正电子发射断层扫描/计算机断层扫描(PET/CT)成像。本文将血清CA125检测与PET/CT成像相结合,检测患者血清中的CA125水平和最大标准化摄取值(SUV)。当CA125水平超过35U/ml且最大SUV值超过2.5时,该检测被视为阳性。本文选取荆州市医院200例患者进行实验,并比较了三种检测方法。50岁以下患者中,单项血清CA125检测、单项PET/CT成像及自动化检测的平均特异性分别为61.24%、79.57%和97.79%。本文设计的自动化早期卵巢癌检测系统可显著提高早期卵巢癌检测的特异性,对早期卵巢癌检测具有优异的应用价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/11cb4538715b/41598_2024_71863_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/8fad1c51ae78/41598_2024_71863_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/3cb0fdd35283/41598_2024_71863_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/45ba32786edb/41598_2024_71863_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/b721556587d3/41598_2024_71863_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/11cb4538715b/41598_2024_71863_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/8fad1c51ae78/41598_2024_71863_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/3cb0fdd35283/41598_2024_71863_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/45ba32786edb/41598_2024_71863_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/b721556587d3/41598_2024_71863_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efda/11447045/11cb4538715b/41598_2024_71863_Fig5_HTML.jpg

相似文献

1
Automated early ovarian cancer detection system based on bioinformatics.基于生物信息学的早期卵巢癌自动检测系统
Sci Rep. 2024 Oct 2;14(1):22887. doi: 10.1038/s41598-024-71863-9.
2
The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.18F-FDG PET/CT 显像联合 CA125 和 HE4 检测在卵巢癌复发转移诊断中的价值。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7276-7283. doi: 10.26355/eurrev_202007_21882.
3
Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose ([F] FDG) in the detection of recurrent ovarian cancer.CA125 及其动力学参数和正电子发射断层扫描/计算机断层扫描(PET/CT)联合氟脱氧葡萄糖 ([F] FDG) 在复发性卵巢癌检测中的应用。
Med Clin (Barc). 2018 Aug 10;151(3):97-102. doi: 10.1016/j.medcli.2017.11.019. Epub 2017 Dec 21.
4
[Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].[正电子发射断层扫描-CT成像联合血清CA125持续检测在上皮性卵巢癌早期无症状复发诊断中的价值]
Zhonghua Fu Chan Ke Za Zhi. 2007 Jul;42(7):460-3.
5
Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages.[18F]氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描([18F]FDG-PET/CT)以及CA125血清水平和动力学参数在卵巢癌复发早期检测中的价值:组织学亚型和肿瘤分期的影响
Medicine (Baltimore). 2018 Apr;97(17):e0098. doi: 10.1097/MD.0000000000010098.
6
Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels.治疗后卵巢癌患者和 CA125 血清水平升高患者中 FDG PET/CT 的价值。
Mol Imaging Biol. 2012 Feb;14(1):123-9. doi: 10.1007/s11307-010-0468-9.
7
Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.血清CA125对上皮性卵巢癌术后患者的随访监测有临床价值吗?一项12年研究的结果。
J Ovarian Res. 2017 Mar 11;10(1):14. doi: 10.1186/s13048-017-0310-y.
8
Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.卵巢癌复发:使用2-[氟-18]-氟-2-脱氧-D-葡萄糖的全身正电子发射断层扫描的作用
Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):797-803. doi: 10.1007/s00259-001-0750-9. Epub 2002 Mar 19.
9
Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.CA125与RECAF生物标志物联合用于卵巢癌的早期检测。
Tumour Biol. 2011 Aug;32(4):831-8. doi: 10.1007/s13277-011-0186-1. Epub 2011 May 28.
10
The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study.CA125 用于初级保健中卵巢癌和非卵巢癌检测的诊断性能:一项基于人群的队列研究。
PLoS Med. 2020 Oct 28;17(10):e1003295. doi: 10.1371/journal.pmed.1003295. eCollection 2020 Oct.

引用本文的文献

1
Low Serum Cholinesterase Levels Predict Poor Prognosis in Patients with Ovarian Cancer.低血清胆碱酯酶水平预示卵巢癌患者预后不良。
Int J Gen Med. 2025 Feb 25;18:1023-1033. doi: 10.2147/IJGM.S509718. eCollection 2025.
2
Inflammation and Immune Escape in Ovarian Cancer: Pathways and Therapeutic Opportunities.卵巢癌中的炎症与免疫逃逸:途径与治疗机遇
J Inflamm Res. 2025 Jan 21;18:895-909. doi: 10.2147/JIR.S503479. eCollection 2025.

本文引用的文献

1
Bioinformatics analysis of neutrophil-associated hub genes and ceRNA network construction in septic cardiomyopathy.脓毒性心肌病中性粒细胞相关枢纽基因的生物信息学分析及 ceRNA 网络构建。
Aging (Albany NY). 2024 Aug 30;16(19):12833-12849. doi: 10.18632/aging.206092.
2
Biomarkers and Strategies for Early Detection of Ovarian Cancer.卵巢癌的早期检测的生物标志物和策略。
Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2504-2512. doi: 10.1158/1055-9965.EPI-20-1057. Epub 2020 Oct 13.
3
The value of 18F-FDG PET/CT imaging combined with detection of CA125 and HE4 in the diagnosis of recurrence and metastasis of ovarian cancer.
18F-FDG PET/CT 显像联合 CA125 和 HE4 检测在卵巢癌复发转移诊断中的价值。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7276-7283. doi: 10.26355/eurrev_202007_21882.
4
Ovarian Cancer: An Overview.卵巢癌概述。
Radiol Technol. 2020 Jul;91(6):561-575.
5
Combining liquid biopsies and PET-CT for early cancer detection.结合液体活检和PET-CT进行早期癌症检测。
Nat Med. 2020 Jul;26(7):1010-1011. doi: 10.1038/s41591-020-0970-9.
6
A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer.CA125 糖型在高级别浆液性卵巢癌监测和随访中的纵向分析。
Gynecol Oncol. 2020 Mar;156(3):689-694. doi: 10.1016/j.ygyno.2019.12.025. Epub 2019 Dec 27.
7
Ovarian cancer: Current status and strategies for improving therapeutic outcomes.卵巢癌:改善治疗效果的现状和策略。
Cancer Med. 2019 Nov;8(16):7018-7031. doi: 10.1002/cam4.2560. Epub 2019 Sep 27.
8
Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.用于早期检测卵巢癌的 CA125 互补纵向血清生物标志物。
Cancer Prev Res (Phila). 2019 Jun;12(6):391-400. doi: 10.1158/1940-6207.CAPR-18-0377. Epub 2019 Apr 9.
9
Simultaneous Measurement of 92 Serum Protein Biomarkers for the Development of a Multiprotein Classifier for Ovarian Cancer Detection.同时测量 92 种血清蛋白生物标志物,以开发用于卵巢癌检测的多蛋白分类器。
Cancer Prev Res (Phila). 2019 Mar;12(3):171-184. doi: 10.1158/1940-6207.CAPR-18-0221. Epub 2019 Feb 1.
10
Early Detection of Ovarian Cancer.卵巢癌的早期检测
Hematol Oncol Clin North Am. 2018 Dec;32(6):903-914. doi: 10.1016/j.hoc.2018.07.003. Epub 2018 Sep 28.